IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens

Journal of Immunology

Volumn 180, Issue 10, 2008, Pages 6816-6826

  Dann, Sara M ^a   Spehlmann, Martina E ^a   Hammond, Dustin C ^a   Iimura, Mitsutoshi ^a   Hase, Koji ^a   Choi, Lillian J ^a   Hanson, Elaine ^a   Eckmann, Lars ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARAGINE; GAMMA INTERFERON; GLYCINE; INTERLEUKIN 6; NITRIC OXIDE; PROTEIN BCL 3; PROTEIN BCL XL; PROTEIN CIAP 2; PROTEIN MCL 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL COLONIZATION; CITROBACTER RODENTIUM; COLON MUCOSA; COLON ULCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTEROBACTERIACEAE; GENE EXPRESSION REGULATION; IMMUNOREGULATION; INTERLEUKIN 6 DEFICIENCY; INTESTINE INFECTION; INTESTINE MUCOSA; MACROPHAGE ACTIVATION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION; ANIMAL; ENTEROBACTER INFECTION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCER;

ANIMALS; APOPTOSIS; CITROBACTER RODENTIUM; ENTEROBACTERIACEAE INFECTIONS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; INTESTINAL MUCOSA; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ULCER;

EID: 45549097533     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.10.6816     Document Type: Article

References (55)

1. Nataro, J. P., and J. B. Kaper. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11: 142-201.
2. Nougayrede, J. P., P. J. Fernandes, and M. S. Donnenberg. 2003. Adheion of enteropathogenic Escherichia coli to host cells. Cell. Microbiol. 5: 359-372.
3. Frankel, G., A. D. Phillips, M. Novakova, H. Field, D. C. Candy, D. B. Schauer, G. Douce, and G. Dougan. 1996. Intimin from enteropathogenic Escherichia coli restores murine virulence to a Citrobacter rodenlium eaeA mutant: induction of an immunoglobulin A response to intimin and EspB. Infect. Immun. 64: 5315-5325.
4. Luperchio, S. A., and D. B. Schauer. 2001. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hypcrplasia. Microbes Infect. 3: 333-340.
5. Johnson, E., and S. W. Barthold. 1979. The ultrastructure of transmissible murine colonic hyperplasia. Am. J. Pathol. 97: 291-313.
6. Schauer, D. B., and S. Falkow. 1993. The cae gene of Citrobacter freundii bio-type 4280 is necessary for colonization in transmissible murine colonic hyperplasia. Infect. Immun. 61: 4654-4661.
7. Vallance, B. A., W. Deng, L. A. Knodler, and B. B. Finlay. 2002. Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection. Infect. Immun. 70: 2070-2081.
8. Maaser, C., M. P. Housley, M. Iimura, J. R. Smith, B. A. Vallance, B. B. Finlay, J. R. Schreiber, N. M. Varki, M. F. Kagnoff, and L. Eckmann. 2004. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect. Immun. 72: 3315-3324.
9. Bry, L., and M. B. Brenner. 2004. Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium. an attaching and effacing pathogen. J. Immunol. 172: 433-441.
10. Vallance, B. A., W. Deng, M. De Grado, C. Chan, K. Jacobson, and B. B. Finlay. 2002. Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen Citrobacter rodentium in infected mice. Infect. Immun. 70: 6424-6435.
11. Simmons, C. P., N. S. Goncalves, M. Ghaem-Maghami, M. Bajaj-EIliott, S. Clare, B. Neves, G. Frankel, G. Dougan, and T. T. MacDonald. 2002. Impaired resistance and enhanced pathology during infection with a noninvasive, attach-ing-effacing enteric bacterial pathogen, Citrobacter rodenlium. in mice lacking IL-12 or IFN-γ. J. Immunol. 168: 1804-1812.
12. Goncalves, N. S., M. Ghaem-Maghami, G. Monteleone, G. Frankel, G. Dougan, D. J. Lewis, C. P. Simmons, and T. T. MacDonald. 2001. Critical role for tumor necrosis factor α in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis. Infect. Immun. 69: 6651-6659.
13. Mangan, P. R., L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, and C. T. Weaver. 2006. Transforming growth factor-β induces development of the Th17 lineage. Nature 441:231-234.
14. Hirano, T., K. Yasukawa, H. Harada, T. Taga, Y. Watanabe, T. Matsuda, S. Kashiwamura, K. Nakajima, K. Koyama, A. Iwamatsu, et al. 1986. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324: 73-76.
15. Gadient, R. A., and U. H. Otten. 1997. Interleukin-6 (IL-6): a molecule with both beneficial and destructive potentials. Prog. Neurobiol. 52: 379-390.
16. Kishimoto, T. 2005. Interleukin-6: from basic science to medicine: 40 years in immunology. Annu. Rev. Immunol. 23: 1-21.
17. Muraguchi, A., T. Hirano, B. Tang, T. Matsuda, Y. Horii, K. Nakajima, and T. Kishimoto. 1988. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J. Exp. Med. 1 67: 332-344.
18. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkemagel, H. Bluethmann, and G. Kohler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368: 339-342.
19. Bromander, A. K., L. Ekman, M. Kopf, J. G. Nedrud, and N. Y. Lycke. 1996. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection. J. Immunol. 156: 4290-4297.
20. Alonzi, T., E. Fattori, D. Lazzaro, P. Costa, L. Probert, G. Kollias, F. De Benedetti, V. Poli, and G. Ciliberto. 1998. Interleukin 6 is required for the development of collagen-induced arthritis. J. Exp. Med. 187: 461-468.
21. Yamamoto, M., K. Yoshizaki, T. Kishimoto, and H. Ito. 2000. IL-6 is required for the development of Th1 cell-mediated murine colitis. J. Immunol. 164: 4878-4882.
22. Aderka, D., J. M. Le, and J. Vilcek. 1989. IL-6 inhibits lipopolysaccharide-in-duced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol. 143: 3517-3523.
23. Ulich, T. R., S. Yin, K. Guo, E. S. Yi, D. Remick, and J. del Castillo. 1991. Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor β inhibit acute inflammation. Am. J. Pathol. 138: 1097-1101.
24. Dalrymple, S. A., L. A. Lucian, R. Slattery, T. McNeil, D. M. Aud, S. Fuchino, F. Lee, and R. Murray. 1995. Interleukin-6-deficient mice are highly susceptible to Lisleria monocytogenes infection: correlation with inefficient neutrophitia. Infect. Immun. 63: 2262-2268.
25. Ladel, C. H., C. Blum, A. Dreher, K. Reifenberg, M. Kopf, and S. H. Kaufmann. 1997. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect. Immun. 65: 4843-4849.
26. + T helper cell 1 development in interleukin 6-deficient mice infected with Candida albi-cans. J. Exp. Med. 183: 1345-1355.
27. Cooper, H. S., S. N. Murthy, R. S. Shah, and D. J. Sedergran. 1993. Clinico-pathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69: 238-249.
28. Greten, F. R., L. Eckmann, T. F. Greten, J. M. Park, Z. W. Li, L. J. Egan, M. F. Kagnoff, and M. Karin. 2004. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296.
29. Nishihara, H., S. Kizaka-Kondoh, P. A. Insel, and L. Eckmann. 2003. Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2. Proc. Natl. Acad. Sci. USA 100: 8921-8926.
30. + T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
31. Bleier, J. I., V. G. Pillarisetty, A. B. Shah, and R. P. DeMatteo. 2004. Increased and long-term generation of dcndritic cells with reduced function from IL-6-deficient bone marrow. J. Immunol. 172: 7408-7416.
32. Hooper, L. V., T. Midtvedt, and J. I. Gordon. 2002. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22: 283-307.
33. Wang, L., S. Srinivasan, A. L. Theiss, D. Merlin, and S. V. Sitaraman. 2007. Interleukin-6 induces keratin expression in intestinal epithelial cells: potential role of keratin-8 in interleukin-6-induced barrier function alterations. J. Biol. Chem. 282: 8219-8227.
34. Dube, P. H., S. A. Handley, J. Lewis, and V. L. Miller. 2004. Protective role of interleukin-6 during Yersinia enlerocolitica infection is mediated through the modulation of inflammatory cytokines. Infect. Immun. 72: 3561-3570.
35. Zhou, P., E. Li, N. Zhu, J. Robertson, T. Nash, and S. M. Singer. 2003. Role of interleukin-6 in the control of acute and chronic Giardia lamblia infections in mice. Infect. Immun. 71: 1566-1568.
36. Bienz, M., W. J. Dai, M. Welle, B. Gottstein, and N. Muller. 2003. Interleukin-6-deficient mice are highly susceptible to Giardia lamblia infection but exhibit normal intestinal immunoglobulin A responses against the parasite. Infect. Immun. 71: 1569-1573.
37. Koornhof, H. J., R. A. Smego, Jr., and M. Nicol. 1999. Yersiniosis. II: The pathogenesis of Yersinia infections. Eur. J. Clin. Microbiol. Infect. Dis. 18: 87-112.
38. Spahn, T. W., C. Maaser, L. Eckmann, J. Heidemann, A. Lugering, R. Newberry, W. Domschke, H. Herbst, and T. Kucharzik. 2004. The lymphotoxin-β receptor is critical for control of murine Citrobacter rodentium-induced colitis. Gastro-enterology 127: 1463-1473.
39. Eckmann, L. 2003. Mucosal defences against Giardia. Parasite Immunol. 25: 259-270.
40. Wiles, S., S. Clare, J. Harker, A. Huett, D. Young, G. Dougan, and G. Frankel. 2004. Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cell. Microbiol. 6: 963-972.
41. VanCott, J. L., M. A. Franco, H. B. Greenberg, S. Sabbaj, B. Tang, R. Murray, and J. R. McGhee. 2000. Protective immunity to rotavirus shedding in the ab-sence of interleukin-6: Th1 cells and immunoglobulin A develop normally. J. Virol. 74: 5250-5256.
42. Iimura, M., R. L. Gallo, K. Hase, Y. Miyamoto, L. Eckmann, and M. F. Kagnoff. 2005. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J. Immunol. 174: 4901-4907.
43. + T helper cells. Cell 126: 1121-1133.
44. Sawada, T., L. A. Falk, P. Rao, W. J. Murphy, and D. H. Pluznik. 1997. IL-6 induction of protein-DNA complexes via a novel regulatory region of the induc-ible nitric oxide synthase gene promoter: role of octamer binding proteins. J. Immunol. 158: 5267-5276.
45. Sokol, H., P. Seksik, L. Rigottier-Gois, C. Lay, P. Lepage, I. Podglajen, P. Marteau, and J. Dore. 2006. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm. Bowel Dis. 12: 106-111.
46. Masseret, E., J. Boudeau, J. F. Colombel, C. Neut, P. Desreumaux, B. Joly, A. Cortot, and A. Darfeuille-Michaud. 2001. Genetically related Escherichia coli strains associated with Crohn's disease. Gut 48: 320-325.
47. Porras, M., M. T. Martin, P. C. Yang, J. Jury, M. H. Perdue, and P. Vergara. 2006. Correlation between cyclical epithelial barrier dysfunction and bacterial translo-cation in the relapses of intestinal inflammation. Inflamm. Bowel Dis. 12: 843-852.
48. Savkovic, S. D., A. Koutsouris, and G. Hecht. 1997. Activation of NF-κB in intestinal epithelial cells by enteropathogenic Escherichia coli. Am. J. Physiol. 273:C1160-C1167.
49. Schilling, D., K. Thomas, K. Nixdorff, S. N. Vogel, and M. J. Fenton. 2002. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAPymyeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages. J. Immunol. 169: 5874-5880.
50. Gibson, D. L., C. Ma, C. M. Rosenberger, K. S. B. Bergstrom, Y. Valdez, J. T. Huang, M. A. Khan, and B. A. Vallance. 2008. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-in-duced colitis. Cell. Microbiol. 10: 388-403.
51. Atreya, R., J. Mudter, S. Finotto, J. Mullberg, T. Jostock, S. Wirtz, M. Schutz, B. Bartsch, M. Holtmann, C. Becker, et al. 2000. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat. Med. 6: 583-588.
52. Naito, Y., T. Takagi, K. Uchiyama, M. Kuroda, S. Kokura, H. Ichikawa, R. Yanagisawa, K. Inoue, H. Takano, M. Satoh, et al. 2004. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice. Int. J. Mol. Med. 14: 191-196.
53. Kida, H., M. Yoshida, S. Hoshino, K. Inoue, Y. Yano, M. Yanagita, T. Kumagai, T. Osaki, I. Tachibana, Y. Saeki, et al. 2005. Protective effect of IL-6 on alveolar epithelial cell death induced by hydrogen peroxide. Am. J. Physiol. 288: L342-L349.
54. Bhattacharya, S., R. M. Ray, and L. R. Johnson. 2005. STAT3-mediated transcription of Bcl-2, Mcl-1 and C-IAP2 prevents apoptosis in polyamine-depleted cells. Biochem. J. 392: 335-344.
55. Ito, H., M. Takazoe, Y. Fukuda, T. Hibi, K. Kusugami, A. Andoh, T. Matsumoto, T. Yamamura, J. Azuma, N. Nishimoto, et al. 2004. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 126: 989-996.